Free-cash-flow proxy increased 37.1%
Free-cash-flow proxy changed +37.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +37.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Capital expenditure changed -98.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +34.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -31.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -27.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current assets changed -26.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -31.5% from the comparable as-filed period.
Operating margin changed -3612 basis points from the comparable as-filed period.
Operating income changed +18.0% from the comparable as-filed period.
Gross margin changed -356 basis points from the comparable as-filed period.
Total assets changed -20.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed -59.6% from the comparable as-filed period.
Capex / revenue changed -1373 basis points from the comparable as-filed period.
SBC / revenue changed -4516 basis points from the comparable as-filed period.
Revenue changed -23.4% from the comparable as-filed period.
Inventory / revenue changed +6160 basis points from the comparable as-filed period.
Gross profit changed -28.7% from the comparable as-filed period.
Free-cash-flow margin changed +6702 basis points from the comparable as-filed period.
Operating cash-flow margin changed +5329 basis points from the comparable as-filed period.
Working capital / assets changed -598 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -3122 basis points from the comparable as-filed period.
Cost of revenue changed -17.7% from the comparable as-filed period.
Current ratio changed -23.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -4.9% from the comparable as-filed period.
Current liabilities changed -4.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.